In this framework, the aim of our study was to evaluate the expression of PATZ1, an emerging cancer-related protein suggested as a diagnostic marker in different cancers, in correlation with the expression of PD-L1, a major target of immunotherapy, in NSCLC. The gene discussed is CD274; the disease is non-small cell lung carcinoma.